Neurocrine Biosciences, Inc. (NBIX)
163.21
-0.67
(-0.41%)
USD |
NASDAQ |
Jun 08, 16:00
163.21
0.00 (0.00%)
After-Hours: 19:29
Neurocrine Biosciences Profit Margin (Quarterly) : 24.30% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 13.29% |
| Amgen, Inc. | 21.02% |
| Iovance Biotherapeutics, Inc. | -110.7% |
| Voyager Therapeutics, Inc. | -1.08K% |
| Incyte Corp. | 23.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.45% |
| Return on Assets | 15.55% |
| Return on Invested Capital | 19.40% |
| Gross Profit Margin (Quarterly) | 98.31% |
| Operating Margin (Quarterly) | 22.84% |
| Return on Net Operating Assets | 46.96% |